Carry forward the banner of national medicine, create a world-famous brand, establish the Zhengqing centennial brand, and become an envoy of human health.
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Founded in 1992, it is a national high-tech enterprise engaged in pharmaceutical product research and development, production, and sales. It is also a national key leading enterprise in agricultural industrialization, one of the top ten in self-innovation capability among large and medium-sized industrial enterprises nationwide, and a national high-tech demonstration enterprise for traditional Chinese medicine modernization.
Zhengqing Group is located in Huaihua High-tech Zone, covering an area of 230 mu (150 mu for the pharmaceutical factory, 50 mu for the API factory, and 30 mu for the seedling rapid propagation base). It has a germplasm resource garden for traditional Chinese medicinal materials, a seedling rapid propagation base, a medicinal source base, an API factory, and eight preparation production lines. Among them, one information-based, intelligent injection production line meets EU standards, with an annual production capacity reaching 5 billion yuan.
Zhengqing Group has its own scientific research platform, which has established a research platform of 'one station, one institute, one center' ('1 station' refers to Academician Liu Liang Workstation, '1 institute' refers to Qifengteng Research Institute, and '1 center' refers to the National Technology Innovation Center for New Traditional Chinese Medicines, in which the group participated). The company's expert team includes Professor Liu Liang, academician of the Chinese Academy of Engineering and honorary chancellor of Macau University of Science and Technology, who is a scientist at Zhengqing Group, and Academician Zhong Nanshan serves as the chairman of the Strategic Consulting Committee of Qifengteng Research Institute.
Zhengqing Group holds 55 authorized invention patents, has won 3 national science and technology awards, 3 provincial science and technology awards, and 7 municipal science and technology awards. It has developed more than ten national new drugs, including Zhengqing Fengtongning Sustained Release Tablets, Ganoderma Lucidum Oral Liquid, and Bosscao. Zhengqing Fengtongning Sustained Release Tablets are China's first sustained-release traditional Chinese medicine product, filling a gap in domestic sustained-release preparations for traditional Chinese medicine. Among them, Zhengqing Fengtongning, discovered to be a drug that can specifically inhibit mPGES-1 (microsomal prostaglandin E2 synthase-1), won the second prize of the National Science and Technology Progress Award; in December 2018, the China Association of Traditional Chinese Medicine released the "Fourth Traditional Chinese Medicine Major Product Forum and Traditional Chinese Medicine Major Product Technology Competitiveness Report," and Zhengqing Fengtongning ranked first among the most technologically competitive major traditional Chinese medicine products in Hunan Province and among the top for rheumatoid arthritis medication nationwide; Zhengqing Qingre Jiedu Granules are the recommended traditional Chinese medicine for the prevention and treatment of novel coronavirus infection pneumonia in Hunan Province.
Zhengqing Group is vigorously implementing the "one body, two wings" strategy, which means strengthening the main body and expanding both wings simultaneously. Through the implementation of the "double two billion" development plan, in five years, the sales output value of leading products such as Zhengqing Fengtongning, Houttuynia Cordata Injection, Qingre Jiedu Granules, and Ganoderma Lucidum Oral Liquid will exceed 2 billion yuan; the two wings will expand simultaneously, developing from the upstream and downstream of products to achieve a full industry chain operation encompassing planting, production, sales, and integration of medicine and healthcare, growing to a scale of 3 billion yuan in five years and 10 billion yuan in ten years, becoming an excellent traditional Chinese medicine enterprise.
Production Approval
New Drugs and Generic Drugs
Authorized Invention Patents
National Quality Standard Formulation
Science and Technology Progress Awards
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地